AzTrials
AzTrials

Upper Extremity DisordersQuickDASH-CATNCT07750028

Catalan Translation and Psychometric Validation of the QuickDASH

An observational study of Upper Extremity Disorders, run by Corporacion Parc Tauli at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Patient-reported outcome measures (PROMs) are essential tools for assessing upper extremity disability from the patient's perspective and are increasingly incorporated into routine clinical practice and research. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Upper Extremity Disorders
How many people
100 participants
Where
1 siteSpain
Study dates
1 Dec 2026to Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult Catalan-speaking patients (18 years or older) presenting with an upper extremity musculoskeletal disorder (acute or chronic) at the outpatient upper extremity clinic of Parc Taulí Hospital Universitari (Sabadell, Spain), able to read and understand written Catalan and to provide written informed consent

Who may be able to join

  • Age 18 years or older. Native or fluent Catalan speaker. Diagnosis of an upper extremity musculoskeletal disorder requiring assessment using the QuickDASH questionnaire. Able to read and understand written Catalan. Able and willing to provide written informed consent. Able to complete the questionnaire independently.

Who cannot join

  • Cognitive impairment preventing questionnaire completion. Severe neurological or psychiatric disorders interfering with questionnaire interpretation. Inability to read or understand Catalan. Refusal or inability to provide written informed consent. Any other condition that, in the opinion of the investigator, could compromise participation or interpretation of questionnaire results.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ana Scott-Tennent De Rivas, MD contact

+34650574958

dra.anascotttennent@gmail.com

Spain1 site
  • Parc Taulí Hospital Univesritari

    Sabadell, Barcelona, 08208

    Ana Scott-Tennent De Rivas, MD, 0034-650574958, dra.anascotttennent@gmail.com

    Francesc Mercano Fernandez, MD

Other trials in Spain

About this study

Official title: Translation, Cross-cultural Adaptation and Psychometric Validation of the Catalan Version of the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH-CAT)

Patient-reported outcome measures (PROMs) are essential tools for assessing upper extremity disability from the patient's perspective and are increasingly incorporated into routine clinical practice and research. The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is one of the most widely used PROMs in upper limb surgery worldwide. Although the questionnaire has been translated and validated into multiple languages, no officially translated and psychometrically validated Catalan version is currently available. The aim of this study is to translate, cross-culturally adapt and psychometrically validate the Catalan version of the QuickDASH according to internationally accepted recommendations for PROM translation and validation. The project consists of two sequential phases. Phase I comprises forward translation, synthesis, back-translation, expert committee review and cognitive debriefing. Phase II consists of a prospective observational psychometric validation study in Catalan-speaking adults with upper extremity disorders. The resulting instrument is expected to become the official Catalan version of the QuickDASH for use in clinical practice and research.

Read the detailed description

Patient-reported outcome measures (PROMs) have become an essential component of modern healthcare by providing standardized assessment of symptoms, disability and treatment outcomes directly from the patient's perspective. Their routine use has increased considerably during the last decade owing to recommendations from international scientific societies and their incorporation into both clinical research and routine outcome assessment. The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is among the most frequently used PROMs for evaluating upper extremity disability. Compared with the original 30-item DASH questionnaire, the abbreviated 11-item QuickDASH maintains excellent psychometric performance while substantially reducing respondent burden, facilitating its use in everyday clinical practice. Despite the widespread use of Catalan within the healthcare system in Catalonia, no officially translated and psychometrically validated Catalan version of the QuickDASH is currently available. Consequently, clinicians and researchers frequently rely on Spanish versions that may not fully reflect linguistic and cultural characteristics specific to Catalan-speaking populations. The primary objective of this study is to produce an officially translated, culturally adapted and psychometrically validated Catalan version of the QuickDASH following internationally accepted methodology and the recommendations established by the Institute for Work \& Health (IWH), copyright holder of the DASH and QuickDASH questionnaires. The translation process will include two independent forward translations, synthesis of both versions, two independent back-translations, multidisciplinary expert committee review and cognitive debriefing in Catalan-speaking patients. Once the final Catalan version has been established, a prospective observational validation study will evaluate its psychometric properties in approximately 100 adult patients presenting with upper extremity disorders at Parc Taulí Hospital Universitari. Psychometric evaluation will include assessment of internal consistency, test-retest reliability, construct validity, measurement error, responsiveness and floor and ceiling effects according to internationally accepted standards for PROM validation studies. The availability of an officially validated Catalan QuickDASH is expected to facilitate standardized outcome assessment in Catalan-speaking populations, improve comparability between international studies and promote the incorporation of patient-reported outcomes into routine clinical practice.

Keywords
QuickDASH;, Disabilities of the Arm, Shoulder and Hand, Patient-Reported Outcome Measures, Outcome Assessment, PROM, Cross-cultural Adaptation, Translation, Validation Study, Questionnaire, Catalan, Psychometric Validation, Upper Extremity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07750028
Study groupRoleWhat they receive
Catalan QuickDASH Validation CohortAdult Catalan-speaking patients presenting with upper extremity disorders who will complete the Catalan version of the QuickDASH as part of the psychometric validation study. Participants will undergo questionnaire assessment at baseline and a subgroup will complete a second assessment for evaluation of test-retest reliability according to the study protocol.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cross-cultural adaptation and psychometric validation of the Catalan QuickDASH

    Successful translation, cross-cultural adaptation and psychometric validation of the Catalan version of the Quick Disabilities of the Arm, Shoulder and Hand questionnaire following internationally accepted recommendations, including cognitive debriefing and expert committee review.

    Measured: Baseline and completion of the translation and validation process (approximately 12 months).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2026
  2. Study start1 Dec 2026 (estimated)
  3. Primary completionFeb 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07750028
Sponsor's protocol ID
QuickDASH-CAT-2026
Other IDs
CEIm: 2026.036-50
Acronym
QuickDASH-CAT
Status last verified
Aug 2026
First submitted
2 Aug 2026
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared. Requests for access to anonymized data may be considered by the Principal Investigator and the sponsor on reasonable request, in accordance with institutional policies, ethical approval and applicable data protection regulations.

Publications

  • Mokkink LB, et al. COSMIN Study Design Checklist for Patient-reported Outcome Measurement Instruments. 2019.

  • Institute for Work & Health. Guidelines for the Translation and Cross-Cultural Adaptation of the DASH & QuickDASH Outcome Measures. Toronto: Institute for Work & Health; 2007.

  • Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001 Apr-Jun;14(2):128-46.

    PubMed 11382253

Questions about this trial

What is this clinical trial studying?

An observational study of Upper Extremity Disorders, run by Corporacion Parc Tauli at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ana Scott-Tennent De Rivas, MD (+34650574958, dra.anascotttennent@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cross-cultural adaptation and psychometric validation of the Catalan QuickDASH (time frame: Baseline and completion of the translation and validation process (approximately 12 months).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07750028, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in